Deep Track Capital’s Soleno Therapeutics SLNO Stock Holding History

Deep Track Capital’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-1,078,710	Closed	-$36.1M	–	79
2026 Q1	$36.1M	Buy	1,078,710 +78,710	+8%	+$3.09M	0.59%	41
2025 Q4	$46.3M	Buy	+1,000,000	New	+$54.8M	0.83%	31

Deep Track Capital's SLNO Position: Q2 2026 in Review

Deep Track Capital sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 1,078,710 shares — an estimated $36.1M sold.

Deep Track Capital first reported a position in SLNO in Q4 2025 and held it in 2 quarters. The position peaked at $46.3M in Q4 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

Deep Track Capital reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
Deep Track Capital sold 1,078,710 Soleno Therapeutics shares in Q2 2026, an estimated $36.1M.
Deep Track Capital first reported a position in Soleno Therapeutics in Q4 2025 and held it in 2 quarters.
Deep Track Capital's Soleno Therapeutics position peaked at $46.3M in Q4 2025.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on Deep Track Capital's 13F filing for Q2 2026, filed 14 Aug 2026.